tiprankstipranks
Trending News
More News >
NeoGenomics (NEO)
NASDAQ:NEO
US Market

NeoGenomics (NEO) Financial Statements

Compare
1,925 Followers

NeoGenomics Financial Overview

NeoGenomics's market cap is currently $1.18B. The company's EPS TTM is $0.06; its P/E ratio is -2.79; NeoGenomics is scheduled to report earnings on February 17, 2026, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 727.33M$ 660.57M$ 591.64M$ 509.73M$ 484.33M
Gross Profit$ 282.54M$ 290.10M$ 244.60M$ 187.90M$ 187.06M
Operating Income$ -66.08M$ -92.11M$ -107.74M$ -157.62M$ -118.75M
EBITDA$ 1.75M$ -1.51M$ -17.61M$ -82.33M$ -65.40M
Net Income$ -108.03M$ -78.73M$ -87.97M$ -144.25M$ -8.35M
Balance Sheet
Cash & Short-Term Investments$ 159.62M$ 386.84M$ 415.20M$ 437.99M$ 515.39M
Total Assets$ 1.36B$ 1.64B$ 1.68B$ 1.74B$ 1.87B
Total Debt$ 472.28M$ 605.33M$ 611.68M$ 610.93M$ 612.79M
Net Debt$ 312.66M$ 238.32M$ 269.19M$ 347.75M$ 295.96M
Total Liabilities$ 523.27M$ 735.70M$ 739.69M$ 742.01M$ 761.50M
Stockholders' Equity$ 836.56M$ 902.34M$ 941.54M$ 998.02M$ 1.11B
Cash Flow
Free Cash Flow$ -21.78M$ -34.04M$ -30.70M$ -96.88M$ -90.86M
Operating Cash Flow$ 5.23M$ 7.02M$ -1.95M$ -65.99M$ -26.72M
Investing Cash Flow$ -12.34M$ 12.86M$ 76.71M$ 517.00K$ -632.37M
Financing Cash Flow$ -200.29M$ 4.65M$ 4.55M$ 11.83M$ 725.28M
Currency in USD

NeoGenomics Earnings and Revenue History

NeoGenomics Debt to Assets

NeoGenomics Cash Flow

NeoGenomics Forecast EPS vs Actual EPS